Journals / Türkiye Aile Hekimliği Dergisi / 2016 / Cilt: 20 - Sayı: 2

Obesity and Insulin Resistance Rates in a Population Under 40 Years Old Who Admitted to a Family Medicine Outpatient Clinic

Bir Aile Hekimliği polikliniğine başvuran kırk yaş altı populasyonda obezite ve insülin direnci oranları

Pages
50–53
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Life style modification should be encouraged and should be emphasized in every visit in this insulin resistant and/or obese population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Chronic diseases are seen more frequently after the age 40s.
📊
Key Findings & Data:In this retrospective study, our aim is to evaluate the insulin resistance and obesity rates in a population who admitted to our Check-Up clinic without any known chronic disease under 39 years and younger.
💡
Conclusion & Impact:Life style modification should be encouraged and should be emphasized in every visit in this insulin resistant and/or obese population.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Chronic diseases are seen more frequently after the age 40s. Insulin resistance can affect multiple organ systems in our body like reproductive system (Amenorrhea, hirsutism, infertility), lipid metabolism (High Low density lipoprotein levels), endocrine system (diabetes mellitus) and etc. In this retrospective study, our aim is to evaluate the insulin resistance and obesity rates in a population who admitted to our Check-Up clinic without any known chronic disease under 39 years and younger. Methods: People who are admitted to our checkup clinic without any known chronic disease (diabetes, mellitus, hypertension and etc.) and without using insulin sensitizer drugs were evaluated retrospectively. Insulin resistance was calculated by homeostatic model assessment method and presence of insulin resistance was accepted as the values equal and above 2,7. Obesity was accepted as the body mass index was 30 and over. Results: A total of 90 people (27 men, 63 women, age: 31,06±6,01 years) were evaluated. Insulin resistance was found in 48,9% of our subject and obesity was found in %37,8 of our population. In our obese population 70,5% of them have insulin resistance. Discussion: Insulin resistance was accepted to be the main risk factor of many diseases like dyslipidemia, hypertension, infertility, diabetes mellitus and even cancer. Obesity is the main reason of insulin resistance and was accepted to be a pandemic disorder. According to our results obese people have more common insulin resistance in comparison with normal weighted people (70,5% vs %35). Recent guidelines advise to start obesity management with patients who have a BMI >= 30, or those who have a BMI >= 27 if concomitant obesity-related risk factors or diseases exist. Life style modification should be encouraged and should be emphasized in every visit in this insulin resistant and/or obese population.

Özet

Amaç: Kronik hastalıklar 40'lı yaşlardan sonra daha sık görülür. İnsülin direnci, üreme sistemi (amenore, hirsutizm, infertilite vb), yağ metabolizması (yüksek ve düşük molekül ağırlıklı lipoprotein seviyeleri), endokrin sistem (diyabet) gibi vücudumuzda çoklu organ sistemlerini etkiler. Bu retrospektif çalışmada amacımız 39 yaş ve altı Check-Up polikliniğimize başvuran ve bilinen kronik hastalığı olmayan bireylerde insülin direnci ve obezite oranlarını değerlendirmektir. Yöntem: 40 yaş altı check up polikliniğimize başvuran ve bilinen kronik hastalığı olmayan ve insülin duyarlaştırıcı ilaç kullanmayan bireyler geriye dönük olarak incelendi. İnsülin direnci; homeostatic model değerlendirme (HOMA) metoduyla ölçüldü ve 2,7 ve üzeri değerler insulin direnci varlığı olarak kabul edildi. Obezite vücut kitle indeksinin (VKİ) 30 ve üzeri olması olarak değerlendirildi. Sonuçlar: Toplamda 90 kişi (27 erkek, 63 kadın, yaş ortalaması 31,1±6,0 yıl) kişi değerlendirildi. İnsülin direnci bireylerin %48,9'unda ve obezite %37,8'inde bulundu. Obez popülasyonumuzda insülin direnci %70,5 olarak bulundu. Tartışma: İnsülin direnci kolesterol metabolizma bozuklukları, hipertansiyon, diyabet hatta kanser için bile risk faktörü olarak kabul edilmektedir. Obezite artık pandemik bir hastalık kabul edilen ve insülin direncinin temel risk faktörüdür. Sonuçlarımıza göre obez kişilerde insülin direnci normal kilolulara göre daha sık görülmektedir (70,5%'e karşı %35,0). Son kılavuzlara göre obezite yönetimine VKİ'si 30 ve üzeri olanlarda veya VKİ 27 ve üzeri olup obezite ilişkili hastalığı olanlarda başlanmalıdır. Yaşam tarzı değişiklikleri bu insülin direnci ve/veya obez olan popülasyonda her başvuruda vurgulanmalı ve kişiler desteklenmelidir.

🔖

Cite This Article

BİLGİN, M., BİLGE, U., GÜLTEKİN, G., ÜNLÜOĞLU, İ. (2022). Obesity and Insulin Resistance Rates in a Population Under 40 Years Old Who Admitted to a Family Medicine Outpatient Clinic. Türkiye Aile Hekimliği Dergisi, Cilt: 20 - Sayı: 2, 50–53. https://ajindex.com/articles/626736

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Gupta D, Krueger CB, Lastra G. Over-nutrition, obesity and insulin resistance in the development of ?-cell dysfunction. Curr Diabetes Rev. 2012; 8 (2):76-83
  2. Moller DE, Flier JS. Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med. 1991;325(13):938-48
  3. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001;86:713-8
  4. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132(6):2169-80
  5. Türkiye Endokrinoloji ve Metabolizma Derneği. Diabetes Mellitus Ve Komplikasyonlarının Tanı, Tedavi Ve İzlem Kılavuzu Mayıs 2014 Ankara B1.6 s 25-26. http://www.turkendokrin.org/files/file/DIYABET_TTK_ web.pdf adresinden 29/07/2015 tarihinde indirilmiştir
  6. Türkiye Endokrinoloji ve Metabolizma Derneği. Metabolik Sendrom Kılavuzu. Ankara 2009 s:8. http://www.turkendokrin.org/files/pdf/metabolik_sendrom.pdf adresinden24.07.2016 tarihinde indirilmiştir
  7. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992;340(8825):925-9
  8. Simmons RK, Alberti KG, Gale EA, et al.The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010;53(4):600-5
  9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34 Suppl 1:S62-9
  10. Arcidiacono B, Iiritano S, Nocera A, et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res. 2012;789174
  11. Bilge U, Gültekin G, Bilgin M, Ünlüoğlu İ. Relationship Between Homeostatic Model Assessment Insulin Resistance (HOMA-IR) Values and Glomerular Filtration Rates (GFR): A Retrospective Study. Ankara Med J. 2015;15(4):220-225
  12. Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, Haghazali M, Asgari F. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolicsyndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab. 2010;7:26
  13. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87:507 20
  14. Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension,